Alphabetical search
A| B| C| D| E| F| G| H| I| J| K| L| M| N| O| P| Q| R| S| T| U| V| W| X| Y| Z
Search by Name or Code Test
(Para exportar a PDF debe añadir la ténica a Mi Lista y lickar en Ver Mi lista, selección máxima 25 técnicas)
210
ANTITHROMBIN III ACTIVITY, PLASMA
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Sample extraction:
Add 1 volume of sodium citrate 3.80% for every 9 volumes of blood.
Centrifuge.
Separate plasma.
Freeze specimen if more than 24 h passed since extraction.
Reference V.:
80.00 - 120.00 %
248
ACTIVATED PROTEIN C RESISTANCE, PLASMA
Method:
Coagulometry.
Mounting:
Delivery period:4
Sample:
1 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Sample extraction:
Add 1 volume of sodium citrate 3.80% for every 9 volumes of blood.
This technique cannot be performed in plasma specimens that exhibit prolonged tPA times (tissue plasminogen activator).
Patient preparation:
Patients receiving treatment with heparin or anti vitamin K should discontinue treatment. In the case of oral anticoagulants, treatment should not resume until prothrombin values are normal.
Sample extraction:
In order to obtain platelet-poor plasma, centrifuge sample blood at 2500g for 15 minutes. Remove ¾ top parts of plasma using a pipette (do not pour off) and dispense into a propilene tub. The plasma of the propilene tub must be centrifugated for a second time, at 2500g for 15 minutes. Dispense the double-centrifuged plasma in a propilene tub, frezze immediately and send the specimen frozen to the laboratory.
Interpretation:
Negative: > 1.80 ratio
Review:
11/11/2011
251
ALPHA2-ANTIPLASMIN, PLASMA
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:10
Sample:
1 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Sample extraction:
Add 1 volume of sodium citrate 3.80% for every 9 volumes of blood.
In order to obtain platelet-poor plasma, centrifuge sample blood at 2500g for 15 minutes. Remove ¾ top parts of plasma using a pipette (do not pour off) and dispense into a propilene tub. The plasma of the propilene tub must be centrifugated for a second time, at 2500g for 15 minutes. Dispense the double-centrifuged plasma in a propilene tub, frezze immediately and send the specimen frozen to the laboratory.
Reference V.:
80.0 - 120.0 %
Review:
05/02/2013
272
ANTI A AGGLUTININS, SERUM
Method:
Agglutination.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Anti "A" Inmunes:
Positive: >= to 1/32 Titulo
Negative:
< 1/32 Titulo
Review:
01/03/2004
275
ANTI 'B' AGGLUTININS, SERUM
Method:
Agglutination.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Anti "B" Inmunes:
Positive: >= to 1/32 Titulo
Negative:
< 1/32 Titulo
290
ANTIGENIC COAGULATION INHIBITOR S PROTEIN, PLASMA
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:10
Sample:
1 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Sample extraction:
Add 1 volume of sodium citrate 3.80% for every 9 volumes of blood.
In order to obtain platelet-poor plasma, centrifuge sample blood at 2500g for 15 minutes. Remove ¾ top parts of plasma using a pipette (do not pour off) and dispense into a propilene tub. The plasma of the propilene tub must be centrifugated for a second time, at 2500g for 15 minutes. Dispense the double-centrifuged plasma in a propilene tub, frezze immediately and send the specimen frozen to the laboratory.
Reference V.:
60.00 - 150.00 %
Review:
14/09/2013
292
ANTITHROMBIN III ANTIGENIC, PLASMA
Method:
Immunonephelometry.
Mounting:
Delivery period:8
Sample:
1 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Sample extraction:
Add 1 volume of sodium citrate 3.80% for every 9 volumes of blood.
Centrifuge.
Separate plasma.
Freeze specimen immediately.
Reference V.:
220.00 - 390.00 mg/L * 10.0 = mg/dL
297
ANTIGENIC C PROTEIN INHIBITOR COAGULATION, PLASMA
Method:
Radial Immunodifussion .
Mounting:
Delivery period:8
Sample:
1 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Sample extraction:
Add 1 volume of sodium citrate 3.80% for every 9 volumes of blood.
In order to obtain platelet-poor plasma, centrifuge sample blood at 2500g for 15 minutes. Remove ¾ top parts of plasma using a pipette (do not pour off) and dispense into a propilene tub. The plasma of the propilene tub must be centrifugated for a second time, at 2500g for 15 minutes. Dispense the double-centrifuged plasma in a propilene tub, frezze immediately and send the specimen frozen to the laboratory.
Reference V.:
Males 1.76 - 2.90 mg/L * 34.5 = %
Females 1.67 - 3.16 mg/L * 34.5 = %
Review:
17/06/2013
422
ACETONE, SERUM
Method:
Gas Chromatography - Flame ionization.
Mounting:
Delivery period:9
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Alt. 2 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:

Exposed personnel < 1.72 mmol/L / 0.172 = mg/dL
Ketoacidosis 1.72 - 12.04 mmol/L / 0.172 = mg/dL
Unexposed personnel < 0.34 mmol/L / 0.172 = mg/dL
Toxic C.:
> 3.44 mmol/L / 0.172 = mg/dL
423
ACETIC ACETYL ACID, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:23
Sample:
1 mL Serum (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Reference V.:
20.00 - 200.00 umol/L * 0.010209 = mg/L
Review:
22/03/2004
428
ACETOACETATE, URINE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:16
Sample:
1 mL Urine (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Reference V.:
Not available
Review:
22/03/2004
486
ALKALINE PHOSPHATASE ISOENZYMES, SERUM
Method:
Agarose gel electrophoresis.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Fracción placentaria 1:
0.00 %
Fracción intestinal:
< 14.00 %
Fracción ósea:
Females > 14 Years 20.00 - 74.00 %
Fracción biliar:
Females > 14 Years 1.00 - 14.00 %
Fracción placentaria 2:
0.00 %
Fracción hepática:
Females > 14 Years 18.00 - 72.00 %
Fracción ósea:
Both 1 14 Years 62.00 - 100.00 %
Males > 14 Years 23.00 - 75.00 %
Fracción biliar:
Males > 14 Years 1.00 - 9.00 %
Fracción hepática:
Both 1 14 Years 1.00 - 31.00 %
Males > 14 Years 15.00 - 71.00 %
Fracción biliar:
Both 1 14 Years 1.00 - 7.00 %
Review:
22/10/2013
497
ACID PHOSPHATASE (FRACTIONS), SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Fosf.Acida Prostática:
Males < 26.66 nkat/L * 0.06 = U/L
Review:
06/11/2009
498
ASPARTATE AMINO TRANSFERASE (GOT/AST), SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Reference V.:
< 0.57 uKat/L * 59.988 = U/L
Review:
09/04/2013
499
ALANINE AMINO TRANSFERASE (GPT/ALT), SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Reference V.:
0.00 - 0.92 uKat/L * 60 = U/L
Review:
09/04/2013
501
ALKALINE PHOSPHATASE (ALP, AP), SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Sample extraction:
Do not use EDTA as an anticoagulant.
Reference V.:
Females > 15 Years 0.67 - 2.51 uKat/L * 59.888 = U/L
Males > 20 Years 0.67 - 2.51 uKat/L * 59.888 = U/L
Males 13 15 Years < 12.53 uKat/L * 59.888 = U/L
Both 1 12 Years < 8.35 uKat/L * 59.888 = U/L
Review:
09/04/2013
503
ACID PHOSPHATASE, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
Reference V.:
Females <= to 61.67 nKat/L * 0.06 = U/L
Males < 78.33 nKat/L * 0.06 = U/L
Review:
09/04/2013
507
ALPHA1-HYDROXYBUTYRATE DEHYDROGENASE, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
72.00 - 182.00 U/L
528
AMYLASE, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Reference V.:
< 1.67 uKat/L * 59.988 = U/L
Review:
09/04/2013
529
ANGIOTENSIN CONVERTING ENZYME (ACE), SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Both > 18 Years 0.33 - 1.17 uKat/L * 59.988 = U/L
Both 1 18 Years 0.48 - 1.87 uKat/L * 59.988 = U/L
531
ADA (ADENOSINE DEAMINASE), SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
0.11 - 0.30 uKat/L / 0.017 = U/L
532
AMYLASE ISOENZYMES, SERUM
Method:
Agarose gel electrophoresis.
Mounting:
Delivery period:21
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Pancreatic amylase:
26.00 - 58.00 %
Salivary amilase s2:
35.00 - 61.00 %
Salivary amilase s3 + s4:
3.00 - 16.00 %
535
ALDOLASE, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:2
Sample:
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 125.80 nKat/L * 0.060241 = U/L
553
AMMONIA, PLASMA
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:3
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Plasma Heparin lithium (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Reference V.:
11.20 - 35.40 umol/L * 1.714 = ug/dL
Review:
09/04/2013
567
APOLIPOPROTEIN A-1, SERUM
Method:
Immunoturbidimetry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
Males 13 60 Years 0.95 - 1.86 g/L * 100 = mg/dL
Females 13 60 Years 1.01 - 2.23 g/L * 100 = mg/dL
Males 2 12 Years 0.93 - 1.72 g/L * 100 = mg/dL
Females > 60 Years 0.91 - 2.24 g/L * 100 = mg/dL
Males 0 1 Years 0.61 - 1.64 g/L * 100 = mg/dL
Females 2 12 Years 0.86 - 1.79 g/L * 100 = mg/dL
Females 0 1 Years 0.59 - 1.69 g/L * 100 = mg/dL
Males > 60 Years 0.73 - 1.86 g/L * 100 = mg/dL
Review:
09/04/2013
568
APOLIPOPROTEIN B, SERUM
Method:
Immunoturbidimetry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Reference V.:
Females 13 60 Years 0.53 - 1.82 g/L * 100 = mg/dL
Females 0 1 Years 0.17 - 1.20 g/L * 100 = mg/dL
Males 13 60 Years 0.49 - 1.73 g/L * 100 = mg/dL
Females 2 12 Years 0.51 - 1.26 g/L * 100 = mg/dL
Females > 61 Years 0.64 - 1.82 g/L * 100 = mg/dL
Males > 61 Years 0.54 - 1.63 g/L * 100 = mg/dL
Males 0 1 Years 0.16 - 1.24 g/L * 100 = mg/dL
Males 2 12 Years 0.48 - 1.25 g/L * 100 = mg/dL
Review:
09/04/2013
577
APOLIPOPROTEIN E, SERUM
Method:
Immunonephelometry.
Mounting:
Delivery period:8
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Transport:
Do not freeze specimen.
Reference V.:
27.00 - 45.00 mg/L * 1.0 = mg/L
581
ATHEROGENESIS RATIO, SERUM
Method:
Molecular absorption spectrometry + calculation
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Indice aterogénico:
< 4.00 Indice
Review:
12/04/2007
590
APOLIPOPROTEIN C3, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
16.00 - 45.00 mg/L
591
ATHEROGENIC INDEX (APOB/APO A1), SERUM
Method:
Calculation
Mounting:
Delivery period:1
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Índice APO B/A1:
Females < 0.80 Índice
Males < 0.90 Índice
593
APOLIPOPROTEIN A2, SERUM
Method:
Immunonephelometry.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 0.45 g/L * 100.0 = mg/dL
626
ALBUMIN, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Reference V.:
35.00 - 50.00 g/L * 0.1 = g/dL
674
ALPHA1-ANTITRYPSIN, SERUM
Method:
Immunoturbidimetry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
0.84 - 2.00 g/L * 100 = mg/dL
Review:
09/04/2013
675
ACID ALPHA1-GLYCOPROTEIN, SERUM
Method:
Immunoturbidimetry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Reference V.:
0.50 - 1.20 g/L * 100 = mg/dL
Review:
27/06/2009
684
ALPHA1-ANTITRYPSIN PHENOTYPE, SERUM
Method:
Isoelectric focusing.
Mounting:
Delivery period:20
Sample:
1 mL Serum (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
R.Values:
Alfa-1-antitrypsin activity (% depending on phenotype):
Phenotype MM:
100 %.
Phenotype MS:
80 %.
Phenotype SS:
60 %.
Phenotype MZ:
57 %.
Phenotype ZZ:
15 %.
Reference V.:
Reported for each case
686
ALPHA2-MACROGLOBULIN, SERUM
Method:
Immunonephelometry.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Reference V.:
1.30 - 3.00 g/L * 100.0 = mg/dL
690
ALPHA-FETOPROTEIN, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Sample extraction:
Serum specimens should always be obtained from the mother before amniocentesis.
Reference V.:
< 8.10 ug/L * 0.83 = UI/mL
R.Values:
Risk of Down’s syndrome: value lower than median multiplied by 0.5.
Risk of neural tube defect:
value higher than median multiplied by 2.5.
Review:
09/04/2013
974
ACETYLCHOLINE RECEPTOR ANTIBODIES, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Indeterminate: 0.25 - 0.40 nmol/L
Positive:
> 0.40 nmol/L
Negative:
< 0.25 nmol/L
980
ACTH (ADRENOCORTICOTROPHIC HORMONE), PLASMA
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
< 10.12 pmol/L * 4.54545 = pg/mL
982
ADH (VASOPRESSIN), PLASMA
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:4
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Separate plasma.
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Patient preparation:
Avoid stress on the collection day.
It is recommended that the patient rest for at least one hour before extraction.
Reference V.:
< 6.16 pmol/L * 1.07991 = pg/mL
Review:
15/05/2009
1026
AZATHIOPRINE, SERUM
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:15
Sample:
3 mL Serum (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
R.Values:
Metabolite measurement is recommended for azathioprine monitoring: 6-Thioguanine and 6-methylmercaptopurine in blood.
Therapeutic R.:
40.00 - 300.00 ug/L
1034
ALDOSTERONE, SERUM 120 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:2
Sample:
1 mL Serum 120m (-8 ºC - Freeze)
Alt. 1 mL Plasma 120m Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Plasma 120m Heparin lithium (-8 ºC - Freeze)
Reference V.:

1035
ALDOSTERONE, SERUM 240 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:2
Sample:
1 mL Serum 240 m. (-8 ºC - Freeze)
Alt. 1 mL Plasma 4 h Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Plasma 4 h Heparin lithium (-8 ºC - Freeze)
Reference V.:

1036
ALDOSTERONE, SERUM 360 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Serum 60m (-8 ºC - Freeze)
Alt. 1 mL Plasma 60m Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Plasma 60m Heparin lithium (-8 ºC - Freeze)
Reference V.:
Not available
1061
ANDROGENIC INDEX FREE, SERUM
Method:
Immunochemiluminiscence + calculation
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
Ind.Androg.Libre:
Males > 14 Years 7.40 - 175.00 Ind.
Both 1 14 Years 0.50 - 1.50 Ind.
Females > 14 Years 1.00 - 4.50 Ind.
Review:
14/03/2011
1124
AMINOTERMINAL PROCOLLAGEN I PROPEPTIDE, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:

Postmenopause Females 16.27 - 73.87 ug/L
Premenopause Females 15.30 - 58.59 ug/L
Review:
25/06/2013
1220
AMIODARONE, SERUM
Method:
High efficiency liquid chromatography - Ultraviolet.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:
0.80 - 3.90 umol/L * 0.645161 = ug/mL
Toxic C.:
> 3.90 umol/L * 0.645161 = ug/mL
Review:
15/05/2008
1221
AMIKACIN, SERUM
Method:
Polarized Immunofluorescense.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Specimens must be obtained 30 minutes before next administration (TROUGH) .
Or 30 miutes after endovenous infusionion or 60 minutes after intramuscular administration (PEAK).
Therapeutic R.:

Trough 1.71 - 6.84 umol/L * 0.584795 = ug/mL
Toxic C.:

> 17.10 umol/L * 0.584795 = ug/mL
Peak > 51.30 umol/L * 0.584795 = ug/mL
Therapeutic R.:

34.20 - 51.30 umol/L * 0.584795 = ug/mL
Review:
09/04/2013
1223
AMITRIPTYLINE / NORTRIPTYLINE, SERUM
Method:
High efficiency liquid chromatography - Ultraviolet.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Obtain specimen 12 hours after the last dose.
Toxic C.:
Amitriptilina+Nortriptilina:
> 500.00 ng/mL
Therapeutic R.:

80.00 - 250.00 ng/mL
Review:
30/07/2010
1264
ARSENIC, BLOOD
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
2 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
Sample extraction:
Metal-free tubes (special for the determination of oligoelements) must be used.
Reference V.:
< 310.0 nmol/L * 0.075188 = ug/L
Toxic C.:

Acute exposure 7980.0 - 123690.0 nmol/L * 0.075188 = ug/L
Chronic exposure 1330.0 - 6650.0 nmol/L * 0.075188 = ug/L
Review:
02/04/2008
1265
ALUMINUM, SERUM
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Separate serum as soon as possible.
Use metal-free container.
Centrifuge the specimen as soon as possible.
Reference V.:
< 555.00 nmol/L * 0.02699 = ug/L
Hemodialysis < 1665.00 nmol/L * 0.02699 = ug/L
1279
ANTIMONY, URINE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
5 mL 24h urine (aliquot) (2-8 ºC - Refrigerate)
Sample extraction:
Use metal-free container.
Reference V.:
< 82.00 nmol/L * 0.121803 = ug/L
Toxic C.:
> 8210.00 nmol/L * 0.121803 = ug/L
Review:
02/04/2008
1356
ALDOSTERONA (/CREATININA), ORINA
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
Not available
1360
APOLIPOPROTEIN E GENOTYPE, BLOOD
Method:
Real Time PCR.
Mounting:
Delivery period:21
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
26/02/2010
1406
ADENOVIRUS ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Please mark specimens clearly as "acute" or "convalescent."
Interpretation:
Negative: < 1/256 Titulo
Positive:
>= to 1/256 Titulo
R.Values:
The study of two serum specimens obtained at an interval of 14-21 days is recommended to confirm recent infection.
Review:
12/01/2004
1407
ADENOVIRUS ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 1/24 Titulo
Positive:
>= to 1/24 Titulo
Review:
22/12/2008
1408
ASPERGILLUS FUMIGATUS ANTIBODIES, SERUM
Method:
Indirect hemagglutination.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 1/320 Titulo
Positive:
>= to 1/640 Titulo
Negative:
< 1/320 Titulo
1426
ADRENAL GLAND ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/10 Titulo
Negative:
< 1/10 Titulo
1482
ALPHA INTERFERON ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:22
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/2 Título
Negative:
< 1/2 Título
1552
ANTINEUTROPHIL CYTOPLASM (ANCA) ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
ANCA:
Positive: >= to 1/20 Titulo
Negative:
< 1/20 Titulo
Review:
22/10/2013
1553
ANTINUCLEAR ANTIBODIES (ANA), SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/80 Titulo
Negative:
< 1/80 Titulo
Review:
09/07/2013
1683
ANTIIMMUNOGLOBULIN A ANTIBODIES, SERUM
Method:
Radial Immunodifussion .
Mounting:
Delivery period:12
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
12/01/2004
1717
ANTIPOLIOVIRUS ANTIBODIES IgG, SERUM
Method:
Viral Neutralization
Mounting:
Delivery period:21
Sample:
0.5 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
POLIVIRUS TYPE 2 Ab:
Negative: < 0.5 KUI/L
POLIVIRUS TYPE 3 Ab:
Negative: < 0.5 KUI/L
POLIVIRUS TYPE I Ab:
Negative: < 0.5 KUI/L
Review:
14/09/2012
1721
ARNm E6 and E7 GENES HIGH RISC HPVs DETECTION
Method:
Real Time NASBA+Hibridization with Beacon probes.
Mounting:
Delivery period:11
Sample:
10 mL PreservCyt (2-8 ºC - Refrigerate)
Reference V.:
Negative
Negative
Negative
Negative
Negative
1730
AMPHIPHYSIN ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
23/06/2013
1793
ANTIPATERNAL CYTOTOXIC ANTIBODIES, SERUM AND BLOOD
Method:
Microlymphocyte toxicity.
Mounting:
Delivery period:2
Sample:
10 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 7 mL Total blood Citrate Dextrose Acid (2-8 ºC - Refrigerate)
Sample extraction:
Serum from mother.
Blood from father.
Interpretation:
Doubtful negative: 20.00 - 29.00 % cel.muertas
Doubtful positive:
30.00 - 49.00 % cel.muertas
Positive:
50.00 - 80.00 % cel.muertas
High positive:
> 80.00 % cel.muertas
Negative:
< 20.00 % cel.muertas
Review:
05/03/2004
1839
ACETONE, URINE
Method:
Gas Chromatography - Flame ionization.
Mounting:
Delivery period:9
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
BLV:

End of workday (Acetone) < 0.86 mmol/L * 58.1395 = mg/L
Review:
22/11/2010
1861
AMYLASE, URINE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
3 mL Urine (2-8 ºC - Refrigerate)
Sample extraction:
Alkalinize to pH > 7.
Reference V.:
0.40 - 6.80 uKat/L * 60.241 = U/L
Review:
09/04/2013
1866
AMMONIA EXCRETION (AMMONIACAL NITROGEN), URINE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
5 mL 24h urine (aliquot) (-8 ºC - Freeze)
Request form:
Diuresis required
Sample extraction:
Freeze specimen immediately.
Reference V.:
Both > 12 Years 8.23 - 88.23 mmol/24h * 17 = mg/24h
Both 0 12 Years 32.94 - 170.59 mmol/24h * 17 = mg/24h
Review:
09/04/2013
1946
AMPHETAMINES (SCREENING), URINE
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:1
Sample:
3 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
Negative
Discriminant V.:
500 ug/L
Review:
09/04/2013
1970
ALUMINUM, URINE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:6
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Sample extraction:
End of workday.
Use metal-free container.
BEI:

End of workday (Aluminum) < 5557.50 nmol/g crea * 0.02699 = ug/g crea
Reference V.:

Unexposed personnel < 1852.00 nmol/g crea * 0.02699 = ug/g crea
Review:
30/07/2009
1999
ARSENIC, URINE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
5 mL Urine (2-8 ºC - Refrigerate)
Sample extraction:
Use metal-free container.
Reference V.:
Excreción:
< 665.00 nmol/24h * 0.075188 = ug/24h
Review:
21/11/2010
2026
ALDOSTERONE, URINE
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:4
Sample:
10 mL 24h urine (aliquot) (-8 ºC - Freeze)
Request form:
Diuresis required
Reference V.:
5.82 - 49.90 nmol/24h * 0.36044 = ug/24h
Review:
05/09/2011
2046
AMPHETAMINES (CONFIRMATORY), URINE
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:6
Sample:
15 mL Urine (2-8 ºC - Refrigerate)
Discriminant V.:
200.00 ug/L
Reference V.:
Negative
Review:
14/09/2012
2056
ALPHA-FETOPROTEIN, AMNIOTIC FLUID
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Amniotic fluid (2-8 ºC - Refrigerate)
Reference V.:

Median (gestation) Females 15 Weeks 18.70 mg/L * 83 = UI/mL
Females 16 Weeks 15.70 mg/L * 83 = UI/mL
Females 17 Weeks 13.10 mg/L * 83 = UI/mL
Females 18 Weeks 10.90 mg/L * 83 = UI/mL
Females 19 Weeks 9.10 mg/L * 83 = UI/mL
Females 20 Weeks 7.60 mg/L * 83 = UI/mL
Females 21 Weeks 6.40 mg/L * 83 = UI/mL
2064
ALPHA1-MICROGLOBULIN, URINE
Method:
Immunonephelometry.
Mounting:
Delivery period:11
Sample:
5 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
< 10.00 mg/L
Review:
03/04/2009
2073
ALPHA-FETOPROTEIN + MoM, AMNIOTIC FLUID
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Amniotic fluid (2-8 ºC - Refrigerate)
Request form:
Week of pregnancy is required.
Review:
09/12/2008
2109
ADA (ADENOSINE DEAMINASE), PERICARDIAL FLUID
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Biologic fluid (2-8 ºC - Refrigerate)
Reference V.:
Not available
2116
ADA (ADENOSINE DEAMINASE), ASCITIC FLUID
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Ascites fluid (2-8 ºC - Refrigerate)
Discriminant V.:
> 0.65 uKat/L * 60 = U/L
Reference V.:
< 0.40 uKat/L * 60 = U/L
Review:
09/04/2013
2123
ALBUMIN, CSF
Method:
Immunoturbidimetry.
Mounting:
Delivery period:1
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Both 4 60 Years 100.00 - 300.00 mg/L * 0.1 = mg/dL
Both 1 48 Months < 450.00 mg/L * 0.1 = mg/dL
Review:
09/04/2013
2128
ADRENAL ANTIBODIES PROFILE, SERUM
Method:
Radioimmunoprecipitation.
Mounting:
Delivery period:13
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
It´s necessary the birth date.
Reference V.:
<= to 15.00 U/mL
<= to 15.00 U/mL
<= to 15.00 U/mL
2133
ADA (ADENOSINE DEAMINASE), CSF
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
< 0.15 uKat/L * 6 = U/L
2136
ALPHA-FETOPROTEIN, ASCITIC FLUID
Method:
Chemicalimmuno luminiscense.
Mounting:
Delivery period:1
Sample:
1 mL Biologic fluid (2-8 ºC - Refrigerate)
Reference V.:
Not available
2137
AMYLASE, PLEURAL FLUID
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Biologic fluid (2-8 ºC - Refrigerate)
Reference V.:
Not available
2138
ADA (ADENOSINE DEAMINASE), PLEURAL FLUID
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Pleural fluid (2-8 ºC - Refrigerate)
Reference V.:
< 0.40 uKat/L * 6 = U/L
2141
ALPHA-FETOPROTEIN, PLEURAL FLUID
Method:
Chemicalimmuno luminiscense.
Mounting:
Delivery period:1
Sample:
1 mL Biologic fluid (2-8 ºC - Refrigerate)
Reference V.:
Not available
2173
ALPHA1-ANTITRYPSIN, FECAL
Method:
Immunonephelometry.
Mounting:
Delivery period:6
Sample:
5 g Faeces (2-8 ºC - Refrigerate)
Reference V.:
< 0.30 mg/g heces
2194
ADA (ADENOSINE DEAMINASE), ARTICULAR FLUID
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Biologic fluid (2-8 ºC - Refrigerate)
Reference V.:
Not available
2207
ANTIGENIC S FREE ANTIGENIC PROTEIN, PLASMA
Method:
Radial Immunodifussion .
Mounting:
Delivery period:8
Sample:
1 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Sample extraction:
Add 1 volume of sodium citrate 3.80% for every 9 volumes of blood.
In order to obtain platelet-poor plasma, centrifuge sample blood at 2500g for 15 minutes. Remove ¾ top parts of plasma using a pipette (do not pour off) and dispense into a propilene tub. The plasma of the propilene tub must be centrifugated for a second time, at 2500g for 15 minutes. Dispense the double-centrifuged plasma in a propilene tub, frezze immediately and send the specimen frozen to the laboratory.
Reference V.:
55.00 - 110.00 %
Review:
05/03/2004
2227
ANTI-ACTIVATED FACTOR X ACTIVITY, PLASMA
Method:
Coagulometry.
Mounting:
Delivery period:16
Sample:
1 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Sample extraction:
Add 1 volume of sodium citrate 3.80% for every 9 volumes of blood.
In order to obtain platelet-poor plasma, centrifuge sample blood at 2500g for 15 minutes. Remove ¾ top parts of plasma using a pipette (do not pour off) and dispense into a propilene tub. The plasma of the propilene tub must be centrifugated for a second time, at 2500g for 15 minutes. Dispense the double-centrifuged plasma in a propilene tub, frezze immediately and send the specimen frozen to the laboratory.
Blood sample must be obtained in Citrat tube 4 hours after last Heparine dose.

Reference V.:
0.20 - 0.50 UI/mL
R.Values:
Variable values of reference depending on dose and guideline of administration.
Review:
14/09/2013
2271
ARSENIC, SERUM
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Metal-free tubes (special for the determination of oligoelements) must be used.
Reference V.:
20.00 - 200.00 nmol/L * 0.075019 = ug/L
Review:
02/04/2008
2273
ARSENIC, HAIR
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:11
Sample:
1 g Hair (2-8 ºC - Refrigerate)
Reference V.:
< 8.65 nmol/g seco
Review:
02/04/2008
2419
ANEUPLOIDY CHROMOSOMES X/Y (FISH), BLOOD
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:14
Sample:
3 mL Total blood Sodium heparin (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
15/03/2014
2426
ANEUPLOIDY MOLECULAR STUDY (QF-PCR), AMNIOTIC FLUID
Method:
QF-PCR (Devyser Compact kit)
Mounting:
Delivery period:2
Sample:
2 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Do not send specimen in the syringe.
R.Values:
CF-PCR has a reliability of 99%. This technique does not detect chromosomal abnormalities other than those studied and may not detect mosaic aneuploidy, so it is very important to confirm the result by cytogenetic study.
Reported for each case.
Review:
07/11/2014
2437
ANGELMAN SYNDROME (15q11.2-q13 Del: FISH), BLOOD
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:14
Sample:
3 mL Total blood Sodium heparin (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
27/10/2010
2446
ASSOCIATED HAEMATOLOGIC DISEASES KARYOTYPE, BLOOD
Method:
Chromosomal analysis of the in cellular culture.
Mounting:
Delivery period:15
Sample:
3 mL Total blood Heparin lithium (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not use EDTA as an anticoagulant.
Reference V.:
Reported for each case
R.Values:
Note: The cytogenetic study is subject to limitations, as they can be the existence of a mosaic of low frequency, the presence of cryptic structural alterations that only can to be evident by means of the application of other techniques.

2469
ANEUPLOIDY 13-18-21-X/Y CHROMOSOMES (FISH), AMNIOTIC FLUID
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:6
Sample:
5 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
26/03/2004
2495
ACHONDROPLASIA (FGFR3 GENE: 1138G>A and 1138G>C MUTATIONS), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
26/03/2004
2500
AUTOSOMAL DOMINANT SPINOCEREBELLAR ATAXIAS , BLOOD
Method:
PCR-DNA Fragment analysis.
Mounting:
Delivery period:28
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
22/10/2013
2510
ACHONDROPLASIA (FGFR3 GENE), AMNIOTIC FLUID
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
Review:
30/05/2009
2520
ARRAY CGH PRENATAL (MOLECULAR KARYOTYPE) (60K), AMNIOTIC FLUID
Method:
Array - CGH (Array Comparative Genomic Hybridization).
Mounting:
Delivery period:15
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
2530
ARRAY-CGH POSTNATAL (MOLECULAR KARYOTYPE) (60K), BLOOD
Method:
Array - CGH (Array Comparative Genomic Hybridization).
Mounting:
Delivery period:20
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
17/05/2013
2551
ADH (VASOPRESSIN), PLASMA 15 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:4
Sample:
1 mL Plasma 15 m. Tripotassium EDTA (-8 ºC - Freeze)
Reference V.:
Not available
Review:
15/05/2009
2552
ADH (VASOPRESSIN), PLASMA 30 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:7
Sample:
1 mL Plasma 30m Tripotassium EDTA (-8 ºC - Freeze)
Reference V.:
Not available
2553
ADH (VASOPRESSIN), PLASMA 45 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:7
Sample:
1 mL Plasma 45 m. Tripotassium EDTA (-8 ºC - Freeze)
Reference V.:
Not available
2554
ADH (VASOPRESSIN), PLASMA 60 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:7
Sample:
1 mL Plasma 60m Tripotassium EDTA (-8 ºC - Freeze)
Reference V.:
Not available
2555
ADH (VASOPRESSIN), PLASMA 90 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:7
Sample:
1 mL Plasma 90m Tripotassium EDTA (-8 ºC - Freeze)
Reference V.:
Not available
2556
ADH (VASOPRESSIN), PLASMA 120 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:4
Sample:
1 mL Plasma 120m Tripotassium EDTA (-8 ºC - Freeze)
Reference V.:
Not available
Review:
15/05/2009
2561
ACTH (CORTICOTROPIN), PLASMA 5 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 5 m. Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

2562
ACTH (CORTICOTROPIN), PLASMA 15 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 15 m. Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

2563
ACTH (CORTICOTROPIN), PLASMA 30 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 30m Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

2564
ACTH (CORTICOTROPIN), PLASMA 60 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 60m Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

2565
ACTH (CORTICOTROPIN), PLASMA 120 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 120m Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

2566
ACTH (CORTICOTROPIN), PLASMA 180 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 180m Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

2567
ACTH (CORTICOTROPIN), PLASMA 210 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 210 m. Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

2569
ACTH (CORTICOTROPIN 20:00 h), PLASMA
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
< 6.60 pmol/L / 0.22 = pg/mL
2570
ACTH (CORTICOTROPIN), PLASMA BASELINE
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Baseline plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

2574
ACTH (CORTICOTROPIN), PLASMA 45 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 45 m. Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

2575
ACTH (CORTICOTROPIN), PLASMA 90 m
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 90m Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:

2637
ACUTE LEUKEMIA IMMUNOPHENOTYPE, BLOOD
Method:
Flux cytometry.
Mounting:
Delivery period:6
Sample:
10 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Alt. 1 mL Bone marrow (12-20 ºC - Ambient Temp.)
Sample extraction:
Specimens must be delivered to the laboratory from Monday to Thursday.
Request form:
Clinical information required.
The type of specimen sent is required.
Reference V.:
Antígeno CD19:
Reported for each case
R.Values:
Reported for each case.
Reference V.:
Antígeno CD56:
Reported for each case
2956
ALPHA-GALACTOSIDASE A, SERUM
Method:
Fluorimetry
Mounting:
Delivery period:36
Sample:
3 mL Serum (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Reference V.:
1.95 - 9.20 nmol/ (h x mL)
6022
ANALYSIS OF CONTROL, DRINKING WATER
Method:
Look method for each procedure.
Mounting:
Delivery period:7
Sample:
50 mL Water (Recipient, plastic) (pH<2 Sulfuric Acid)
1000 mL Water (Recipient, sterile) ( Sodium Thiosulfate )
Sample extraction:
Send the two specimens.
In the container were sodium thiosulfate is used as preservative, add 0.10 mL of a 10 % (m / m) sodium thiosulfate solution for every 125 mL of the sample.
6076
AMMONIA, DRINKING WATER
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:7
Sample:
100 mL Water (Recipient, plastic) (pH<2 Sulfuric Acid)
RD 140/2003:
< 0.50 mg/L
6096
AGGRESSIVENESS INDEX, WATER
Method:
Calculation
Mounting:
Delivery period:9
Sample:
250 mL Water (Recipient, plastic)
Parametric V.:
Inert water: 0.00 Indice
Incrusting water:
> 0.00 Indice
Aggressive water:
< 0.00 Indice
Review:
30/05/2008
6200
ALUMINUM, DIALYSATE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
50 mL Dialysis water (Recipient, plastic) (pH<2 Nitric Acid)
UNE 111-301-90:
< 0.0100 mg/L
Review:
27/05/2009
6203
ARSENIC, DIALYSATE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Dialysis water (Recipient, plastic) (pH<2 Nitric Acid)
UNE 111-301-90:
< 0.005 mg/L
Review:
27/05/2009
6214
ALUMINUM, DRINKING WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
RD 140/2003:
< 200.00 ug/L
6219
ARSENICO, DRINKING WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:10
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
RD 140/2003:
< 10.00 ug/L
6234
ANTIMONY, DRINKING WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric acid concentrated (37%).)
RD 140/2003:
< 5.00 ug/L
Review:
27/05/2009
6411
AMMONIA, SWIMMING POOL WATER
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:7
Sample:
100 mL Water (Recipient, plastic) (pH<2 Sulfuric Acid)
Parametric V.:
< 0.50 mg/L
Déc. 23/99 23 Fev, Andalousie < 0.50 mg/L
6524
AEROBIC BACTERIA AT 37ºC, DIALYSATE
Method:
In depth scatter (UNE-EN ISO 6222).
Mounting:
Delivery period:7
Sample:
10 mL Dialysis water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Parametric V.:
Not established.
Review:
03/11/2009
6525
AEROBIC BACTERIA AT 22ºC, DIALYSATE
Method:
In depth scatter (UNE-EN ISO 6222).
Mounting:
Delivery period:8
Sample:
10 mL Dialysis water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Parametric V.:
Not established.
Review:
07/08/2009
6559
AEROBIC BACTERIA AT 30 - 35ºC, DIALYSATE
Method:
In depth scatter (UNE-EN ISO 6222).
Mounting:
Delivery period:7
Sample:
1000 mL Dialysis water (2-8 ºC - Refrigerate)
Sample extraction:
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Parametric V.:
< 100.00 UFC/mL
Review:
24/03/2014
6691
ANIONIC SURFACTANTS, WASTE WATER
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:7
Sample:
15 mL Water (Recipient, plastic) (pH<2 Sulfuric Acid)
DC 130/2003:
< 6.00 mg/L
RD 849/1986:
Type II spill.: 2.01 - 3.00 mg/L
Type I spill.:
3.01 - 6.00 mg/L
Type III spill.:
<= to 2.00 mg/L
Review:
09/05/2008
6713
ARSENICO, WASTE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
DC 130/2003:
< 1.00 mg/L
RD 849/1986:
Type I spill.: 0.51 - 1.00 mg/L
Type III spill.:
<= to 0.50 mg/L
6714
ARSENICO, WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:10
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
6715
ANTIMONY, WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric acid concentrated (37%).)
Parametric V.:
Not established.
Review:
15/07/2009
6716
AMMONIA, WASTE WATER
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:7
Sample:
100 mL Water (Recipient, plastic) (pH<2 Sulfuric Acid)
DC 130/2003:
< 60.00 mg/L
RD 849/1986:
Type II spill.: 15.01 - 50.00 mg/L
Type III spill.:
<= to 15.00 mg/L
6717
AMMONIA, WATER
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:7
Sample:
100 mL Water (Recipient, plastic) (pH<2 Sulfuric Acid)
Parametric V.:
Not established.
6718
ALUMINUM, WASTE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
DC 130/2003:
< 20.00 mg/L
RD 849/1986:
Type I spill.: 1.01 - 2.00 mg/L
Type III spill.:
<= to 1.00 mg/L
6719
ALUMINUM, WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
6720
AGGRESSIVENESS INDEX, DRINKING WATER
Method:
Calculation
Mounting:
Delivery period:9
Sample:
250 mL Water (Recipient, plastic)
RD 140/2003:
-0.50 - 0.50 Indice
Review:
30/05/2008
6724
ACHRILAMIDE, WATER
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:12
Sample:
250 mL Water (Recipient, glass)
6725
ALDEHYDES (FORMALDEHYDE), WASTE WATER
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:12
Sample:
100 mL Water (Recipient, plastic)
RD 849/1986:
Type I spill.: 1.01 - 2.00 mg/L
Type III spill.:
<= to 1.00 mg/L
6730
ARSENICO, SWIMMING POOL WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
6731
ANTIMONY, SWIMMING POOL WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric acid concentrated (37%).)
Parametric V.:
Not established.
Review:
05/06/2009
6732
ANTIMONY, WASTE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric acid concentrated (37%).)
Parametric V.:
Not established.
Review:
05/06/2009
6733
ANTIMONY, DIALYSATE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric acid concentrated (37%).)
Parametric V.:
< 0.006 mg/L
Review:
02/02/2010
6734
ALUMINUM, SWIMMING POOL WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:

Déc. 23/99 23 Fev, Andalousie < 0.30 mg/L
6829
AMMONIA, DIALYSATE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:7
Sample:
100 mL Water (Recipient, plastic) (pH<2 Sulfuric Acid)
Parametric V.:
< 0.20 mg/L
7047
ADENOVIRUS ANTIGEN, FECAL
Method:
Latex particle agglutination.
Mounting:
Delivery period:2
Sample:
2 g Faeces (2-8 ºC - Refrigerate)
Sample extraction:
See general instructions.
Reference V.:
Negative
Review:
04/07/2012
7050
ADULT PARASITES, HELMINTHS
Method:
Macroscopic observation.
Mounting:
Delivery period:7
Sample:
1 Sample/s Worm Physiological serum (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
See general instructions.
Reference V.:
Reported for each case
Review:
06/11/2009
7072
ARTHROPODS' IDENTIFICATION
Method:
Microscopic observation.
Mounting:
Delivery period:5
Sample:
1 Sample/s Parasite (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Identificación artrópodos:
Reported for each case
Review:
02/04/2009
7091
ANTIBIOMYCOBACTERIA, CULTURE
Method:
Radiometry
Mounting:
Delivery period:101
Sample:
1 All Colonies (pure culture) (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
Review:
25/05/2007
7092
ANTIFUNGAL PANEL, CULTURE
Method:
Minimum inhibitory concentration
Mounting:
Delivery period:3
Sample:
1 All Colonies (pure culture) (2-8 ºC - Refrigerate)
Request form:
In order to assess adequately the chemotherapy agents used in vitro, the species must be known. Therefore, if this test is requested, the species should be notified. If not indicated, identification also will be conducted.
Reference V.:
Reported for each case
Review:
11/03/2011
7096
ANTIFUNGAL PANEL (FILAMENTOUS FUNGI), CULTURE
Method:
Minimum inhibitory concentration
Mounting:
Delivery period:21
Sample:
1 All Colonies (pure culture) (2-8 ºC - Refrigerate)
Request form:
In order to assess adequately the chemotherapy agents used in vitro, the species must be known. Therefore, if this test is requested, the species should be notified. If not indicated, identification also will be conducted.
Reference V.:
Reported for each case
8001
ACYL CARNITINE, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 28.00 umol/L * 0.160514 = mg/L
Review:
07/06/2005
8054
ACTIN ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 1/160
Positive:
>= to 1/160
Review:
11/02/2014
8077
ANGIOTENSIN CONVERTING ENZYME (ACE), CSF
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
< 0.05 uKat/L * 59.988 = U/L
Review:
18/04/2015
8142
ANEUPLOIDY CHROMOSOMES 13-18-21-X/Y (FISH), SEMEN
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:18
Sample:
2 mL Semen (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
27/12/2010
8213
ANTI-MULLERIAN HORMONE, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:2
Sample:
1 mL Serum (-8 ºC - Freeze)
Alt. 1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Separate serum as soon as possible.
Reference V.:
Females < 75.68 pmol/L * 0.14 = ng/mL
Males 5.71 - 104.24 pmol/L * 0.14 = ng/mL
Females < 89.96 pmol/L * 0.14 = ng/mL
Males 9.28 - 105.67 pmol/L * 0.14 = ng/mL
Postmenopause Females < 0.57 pmol/L * 0.14 = ng/mL
Stimul. Horm. Resp. Normal:
6.40 - 20.40 pmol/L * 0.14 = ng/mL
High:
> 20.40 pmol/L * 0.14 = ng/mL
Reduced:
< 6.40 pmol/L * 0.14 = ng/mL
Review:
20/02/2014
8221
ADENOVIRUS DNA, BIOLOGICAL FLUID/EXUDATE
Method:
Real Time PCR.
Mounting:
Delivery period:11
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Conjunctival exudate (2-8 ºC - Refrigerate)
Reference V.:
Negative
8243
ADIPONECTIN, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:35
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:

BMI (23.8 - 30.6) Men 0.84 - 16.44 ug/mL
BMI (24.4 - 35.2) Women 3.75 - 23.35 ug/mL
8297
ATRIAL NATRIURETIC FACTOR, PLASMA
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:25
Sample:
1 mL Plasma Tripotassium EDTA Trasylol (-8 ºC - Freeze)
Reference V.:
9.00 - 24.00 pmol/L
8365
ANEUPLOIDY MOLECULAR STUDY (QF-PCR), PRODUCTS OF CONCEPTION
Method:
QF-PCR.
Mounting:
Delivery period:2
Sample:
1 piece/s Fetal Tissue (Reabsorbed remains) (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
R.Values:
CF-PCR has a reliability of 99%. This technique does not detect chromosomal abnormalities other than those studied and may not detect mosaic aneuploidy, so it is very important to confirm the result by cytogenetic study.
Reported for each case.
8375
ACID OROTIC, URINE
8399
ADALIMUMAB ACTIVITY AND NEUTRALIZING ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:16
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Reference V.:
< 10.00 ug/mL
Negative
Review:
21/11/2013
8401
ALDOSTERONE, SERUM 30 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:2
Sample:
1 mL Serum 30m (-8 ºC - Freeze)
Alt. 1 mL Plasma 30m Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Plasma 30m Heparin lithium (-8 ºC - Freeze)
Reference V.:

8402
ALDOSTERONE, SERUM 60 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Serum 60m (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma 60m Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma 60m Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
Not available
8449
ACUTE LEUKEMIA IMMUNOPHENOTYPE, BONY MARROW
Method:
Flow cytometry.
Mounting:
Delivery period:6
Sample:
1 mL Bone marrow Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
The type of specimen sent is required.
Sample extraction:
Samples must come to our laboratory from Monday to Thursday. Wednesday is the last possible day for blood collection.
Reference V.:
COMENTARIO:
Reported for each case
R.Values:
Reported for each case.
8450
AQUAPORIN ANTIBODIES IgG (NMO), SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:11
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
8451
ASCITIC FLUID STUDY
Method:
Microscopic observation.
Mounting:
Delivery period:1
Sample:
1 mL Ascites fluid (2-8 ºC - Refrigerate)
Reference V.:
Aspecto:
Transparent
Células mononucleadas:
Reported for each case
Color:
Light yellow
Leucocitos:
< 0.20 10Exp9/L
Linfocitos:
Reported for each case
Neutrófilos:
Reported for each case
Volumen:
Not available
Review:
12/03/2009
8460
ALZHEIMER DISEASE GENETIC PROFILE, BLOOD
Method:
Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Review:
14/05/2014
8478
ANEUPLOIDY MOLECULAR STUDY (QF-PCR), CHORIONIC VILLI
Method:
QF-PCR.
Mounting:
Delivery period:2
Sample:
0.01 g Corial villus (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Use the tubes supplied by this laboratory.
Do not send specimen in the syringe.
R.Values:
CF-PCR has a reliability of 99%. This technique does not detect chromosomal abnormalities other than those studied and may not detect mosaic aneuploidy, so it is very important to confirm the result by cytogenetic study.
Reported for each case.
Review:
01/03/2016
8543
ASIALOGLYCOPROTEIN RECEPTOR ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:30
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Indeterminate: 0.90 - 1.10 Indice
Positive:
> 1.10 Indice
Negative:
< 0.90 Indice
8573
ALPHA1-ANTITRYPSIN DEFICIENCY (SERPINA1 GENE) , BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:20
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
22/10/2013
8578
ANTIMONY, SERUM
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:1
Sample:
5 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Metal-free tubes (special for the determination of oligoelements) must be used.
Reference V.:
Not available
Review:
12/12/2008
8586
ANTIBODIES ANTI POTASSIUM CHANNELS, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:16
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative: < 31.0 pmol/L
Indeterminate:
31.0 - 85.0 pmol/L
Positive:
> 85.0 pmol/L
Review:
15/03/2012
8697
ANEUPLOIDIES MOLECULAR STUDY (QF-PCR), ABORTION SAMPLE
Method:
QF-PCR.
Mounting:
Delivery period:2
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
22/05/2013
8727
AUTOIMMUNE NEUTROPENIA, BLOOD/SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:5
Sample:
50 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
8735
ANEUPLOIDY MOLECULAR STUDY (QF-PCR), BLOOD
Method:
QF-PCR.
Mounting:
Delivery period:2
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
R.Values:
CF-PCR has a reliability of 99%. This technique does not detect chromosomal abnormalities other than those studied and may not detect mosaic aneuploidy, so it is very important to confirm the result by cytogenetic study.
8769
ANTIVIRAL RESISTANCE IN HEPATITIS B, PLASMA
Method:
PCR-Sequenciation.
Mounting:
Delivery period:20
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Serum (-8 ºC - Freeze)
Reference V.:
Reported for each case
8832
ANEUPLOIDIES MOLECULAR EXTENDED STUDY (QF-PCR), ABORTION SAMPLE
Method:
QF-PCR.
Mounting:
Delivery period:2
Request form:
Clinical information required.
Reference V.:
Reported for each case
8835
ARIPIPRAZOL AND DEHIDROARIPIPRAZOL, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
Aripiprazol:
150.00 - 500.00 ug/L * 0.00223 = umol/L
8845
ADALIMUMAB ACTIVITY AND NEUTRALIZING ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Reference V.:
Adalimumab antibodies:
< 10.00 U/mL
Adalimumab:
>= to 5.00 ug/mL
8853
AMITRIPTILINE AND NORTRIPTILINE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Obtain specimen 12 hours after the last dose.
Reference V.:
Not established.
Not established.
Therapeutic R.:
Amitriptiline + Nortriptiline:
80.00 - 200.00 ug/L * 3.7968 = nmol/L
Toxic C.:

> 500.00 ug/L * 3.7968 = nmol/L
8860
ACYLCARNITINES STUDY, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:10
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
1 mL Serum (-8 ºC - Freeze)
Reference V.:
0.02 - 0.84 umol/L
0.03 - 0.30 umol/L
0.03 - 0.51 umol/L
0.03 - 0.55 umol/L
0.05 - 0.50 umol/L
14.00 - 69.74 umol/L
2.40 - 16.30 umol/L
25.00 - 80.00 umol/L
< 0.17 umol/L
< 0.70
< 30.00 umol/L
8882
ALPHA1-ANTITRYPSIN DEFICIENCY (SERPINA1 GENE), AMNIOTIC FLUID
Method:
PCR-Sequencing.
Mounting:
Delivery period:25
Sample:
5 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
Review:
23/10/2009
8901
ANTI TESTICULAR ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Positive: >= to 5.00
Negative:
< 5.00
8908
ANTI-PLATELET ANTIBODIES FRONT HPA 1, SERUM
Method:
MAIPA (monoclonal antibody immobilization platelet antigens)
Mounting:
Delivery period:22
Sample:
5 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
8909
ANTIBODIES PLATELETS IIb-IIIa; Ia-IIa; Ib-IX, SERUM
Method:
MAIPA (monoclonal antibody immobilization platelet antigens)
Mounting:
Delivery period:7
Sample:
5 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
Review:
24/02/2010
8915
ARABINOSE, URINE
Method:
Gas Chromatography.
Mounting:
Delivery period:15
Sample:
100 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
< 50.00 mmol/mol creat.
8932
ANTIPLATELETS ANTIBODIES (TITLE), SERUM
Method:
MAIPA (monoclonal antibody immobilization platelet antigens)
Mounting:
Delivery period:22
Sample:
5 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
8933
ANTIGRANULOCYTES ANTIBODIES (IFI), SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:7
Sample:
5 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
8934
ANTI-GRANULOCYTES ANTIBODIES (MAIGA), SERUM
Method:
MAIGA
Mounting:
Delivery period:22
Sample:
5 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
9200
ALPHA -1 ANTITRYPSINE FECAL CLEARENCE
Method:
Calculation
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Specimen weight is required.
10057
ACTH (CORTICOTROPIN) (8.00 h) POST-DEXAMETHASONE, PLASMA
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Do not use heparin as an anticoagulant.
Freeze specimen immediately.
Reference V.:
< 2.20 pmol/L * 4.54545 = pg/mL
Review:
27/12/2010
10061
ANGELMAN SYNDROME (15q11.2-q13 Del: FISH), AMNIOTIC FLUID
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:14
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
27/10/2010
10064
ANEUPLOIDY 13-18-21-X/Y CHROMOSOMES (FISH), CHORIONIC VILLI
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:18
Sample:
0.01 g Corial villus RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
Do not add formalin.
Reference V.:
Reported for each case
Review:
17/03/2014
10072
ANGELMAN SYNDROME (15q11.2-q13 Del: FISH), CHORIONIC VILLI
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:18
Sample:
0.01 g Corial villus (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
Reference V.:
Reported for each case
Review:
16/10/2014
10074
ANNEXIN V ANTIBODIES IgG, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Indeterminate: 0.80 - 1.25 Índice
Positive:
> 1.25 Índice
Negative:
< 0.80 Índice
10154
ALPHA-INTERFERON, SERUM
Method:
In vitro culture.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 2.00 UI/mL
10197
ANNEXIN V ANTIBODIES IgM, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Indeterminate: 0.80 - 1.25 Índice
Positive:
> 1.25 Índice
Negative:
< 0.80 Índice
10221
AMYLOID A (SAA), SERUM
Method:
Nephelometry - Turbidimetry.
Mounting:
Delivery period:11
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
< 6.50 mg/L
Review:
17/05/2013
10224
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA (PKP2 GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
19/09/2011
10231
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA (DSP GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
06/03/2012
10232
AGOMELATINE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:10
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:
21.00 ug/L
8.80 ug/L
10246
ACANTHAMOEBA spp DNA, BIOPSY
Method:
Polymerase chain reaction.
Mounting:
Delivery period:10
Sample:
1 Sample/s Biopsy (-8 ºC - Freeze)
Alt. 1 Sample/s Tissue (-8 ºC - Freeze)
Reference V.:
Negative
Review:
20/02/2012
10260
ACETAZOLAMIDE, SERUM
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:20
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:
5.00 - 25.00 mg/L
10331
ADAMTS-13 ACTIVITY, PLASMA
Method:
Fluorescence Resonance Energy Transfer.
Mounting:
Delivery period:15
Sample:
2 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Reference V.:
6.00 - 100.00 %
Review:
04/09/2012
10353
ANTIBODIES ANTI POTASSIUM CHANNELS,CSF
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:16
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Positive: > 85.0 pmol/L
Negative:
< 31.00 pmol/L
Indeterminate:
31.0 - 85.0 pmol/L
Review:
27/02/2013
10358
AMMONIA, CSF
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:3
Sample:
0.5 mL Cerebrospinal liquid (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Reference V.:
Not available
10388
ACETOACEYIL-CoA THIOLASE, FIBROBLASTES
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:105
Sample:
1 piece/s Skin Biopsy RPMI media (12-20 ºC - Ambient Temp.)
Sample extraction:
Analysis with special requirements. You should contact the laboratory before extraction and shipment of the sample.
Reference V.:
Reported for each case
Review:
03/09/2012
10606
ADRENOLEUCODYSTROPHIE X-LINKED (ABCD1 GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10607
ALZHEIMER DISEASE TYPE 4 (PSEN2 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10611
ALPORT SYNDROME (COL4A5 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10612
ALPORT SYNDROME (COL4A5 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
23/09/2013
10613
ALZHEIMER DISEASE TYPE 1 (APP GENE: EXONS 16 and 17), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:60
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10614
ALZHEIMER DISEASE TYPE 3 (PSEN1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10615
ALZHEIMER DISEASE TYPE 3 (PSEN1 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10616
ALZHEIMER DISEASE TYPE 4 (PSEN2 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10617
ANDERSEN SYNDROME (KCNJ2 GENE), BLODD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10626
ANGELMAN SYNDROME (MICROSATELIT TEST), BLOOD
10627
ANGELMAN SYNDROME (UBE3A GENE: NGS), BLOOD
Method:
Next Generation Sequencing (NGS).
Mounting:
Delivery period:50
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10628
ANIRIDIA (PAX6 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10629
ANIRIDIA (PAX6 GENE: SECUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10630
APERT SYNDROME (FGFR2 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10639
ATAXIA-APRAXIA OCULOMOTOR (SETX GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10640
ATAXIA-APRAXIA OCULOMOTOR (SETX GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10641
ATAXIA-TELANGIECTASIA (ATM GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10642
ATAXIA-TELANGIECTASIA (ATM GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10643
ATAXIA-TELANGIECTASIA (ATM GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10687
ARRHYTMOGENIC RIGHT VENTRICULAR DYSPLASIA (DSC2 GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10688
ARRYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA (DSG2 GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10689
ARRYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA (DSP GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10835
ALBRIGHT OSTEODYSTROPHY (GNAS1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10895
ALPHA-THALASEMIA (HBA1 and HBA2 GENES: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:16
Sample:
1 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10973
ATAXIA-TELANGIECTASIA (ATM GENE), AMNIOTIC FLUID
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
11031
ARRAY BLOOD GROUPS, BLOOD
11034
ALAGILLE SYNDROME (JAG1 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 piece/s Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11101
ATAXIA-APRAXIA OCULOMOTOR (APTX GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11140
ALAGILLE SYNDROME (JAG1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11164
ARRAY-CGH PRENATAL (MOLECULAR KARYOTYPE) (60K), CHORIONIC VILLI
Method:
Array - CGH (Array Comparative Genomic Hybridization).
Mounting:
Delivery period:11
Sample:
8 mL Corial villus (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
Reference V.:
Reported for each case
11194
APERT SYNDROME (FGFR2 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
03/09/2012
11406
ALPHA-GALACTOSIDASE A, LEUCOCYTES
Method:
Fluorimetry
Mounting:
Delivery period:36
Sample:
3 mL Total blood Heparin lithium (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
It´s necessary the birth date.
It´s necessary to contact previously with the laboratory for study programmation..
Reference V.:
48.00 - 98.00 nmol/h/mg Prot.
Review:
24/09/2012
11412
ADAMTS-13 ANTIBODIES, PLASMA
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:16
Sample:
2 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Reference V.:
Negative
Review:
24/09/2012
11561
ALPHA-GLUCOSIDASE, DRIED BLOOD SPOT
Method:
Fluorimetry
Mounting:
Delivery period:30
Sample:
1 Sample/s Dred Blood Spot (12-20 ºC - Ambient Temp.)
Reference V.:
0.31 - 3.31 umol/21h*disco
11580
ANAPLASMA / EHRLICHIA DNA, BLOOD
Mounting:
Delivery period:23
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Negative
11632
AMYLASE, SALIVA
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Saliva (2-8 ºC - Refrigerate)
Reference V.:
50.00 - 7000.00 uKat/L * 59.988 = U/L
Review:
22/09/2013
11654
ATYPICAL RETT SYNDROME (CDKL5 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:45
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
18/03/2013
11666
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA PF1 (PKP2,DSG2, DSC2, DSP GENES), BLOOD
11667
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA PF2 (JUP and TMEM43 GENES),BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11751
ARRAY-CGH (MOLECULAR KARYOTYPE) (60K), PRODUCTS OF CONCEPTION
Method:
Array - CGH (Array Comparative Genomic Hybridization).
Mounting:
Delivery period:35
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
25/10/2013
11764
ALUMINUM, PLASMA
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
7.5 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Sample extraction:
Separate plasma as soon as possible.
Use metal-free container.
Centrifuge the specimen as soon as possible.
Reference V.:
< 555.00 nmol/L * 0.02699 = ug/L
Hemodialysis < 1665.00 nmol/L * 0.02699 = ug/L
Review:
20/06/2013
11856
ANGELMAN SYNDROME (REGION 15q11: MS-MLPA), BLOOD
Method:
Metilation specífic MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:20
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Review:
08/07/2014
11881
APOLIPOPROTEIN C2, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:10
Sample:
0.5 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
16.00 - 42.00 mg/L
Review:
29/09/2014
11912
ANEUPLOIDY CHROMOSOMES X/Y (FISH), BONE MARROW
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:10
Sample:
3 mL Bone marrow Sodium heparin RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
Reference V.:
Reported for each case
Review:
17/03/2014
11944
ALPERS-HUNTTENLOCHER SYNDROME (POLG GENE: SEC.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:76
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
01/05/2014
14108
AMINOTERMINAL PROCOLLAGEN III PROPEPTIDE, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma (2-8 ºC - Refrigerate)
Reference V.:
0.30 - 0.80 KU/L * 1 = U/mL
Review:
27/05/2014
14228
ARGININOSUCCINIC ACIDURIA (ASL GENE), AMNIOTIC FLUID
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
29/07/2014
14243
ANGIOTENSIN II, PLASMA
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:12
Sample:
2 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Centrifuge at 4ºC.
Freeze specimen immediately.
Reference V.:
20.00 - 40.00 pg/mL * 1 = ng/L
14311
ARRAY CGH PRENATAL (MOLECULAR KARYOTYPE) (60K), UMBILICAL CORD BLOOD
Method:
Array - CGH (Array Comparative Genomic Hybridization).
Mounting:
Delivery period:15
Sample:
5 mL Umbilical cord blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
20/10/2014
14321
ANEUPLOIDY CHROMOSOMES 13-16-18-21-20-X/Y (FISH), SEMEN
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:18
Sample:
2 mL Semen (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
05/12/2014
14339
ASPERGILLUS ANTIGEN, BRONCHOALVEOLAR LAVAGE
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:6
Sample:
2 mL BAL (2-8 ºC - Refrigerate)
2 mL BAS (2-8 ºC - Refrigerate)
Reference V.:
Negative
14376
ALPHA-FODRIN ANTIBODIES IgA , SERUM
Mounting:
Delivery period:21
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 10 Ratio
Review:
14/12/2014
14377
ALPHA-FODRIN ANTIBODIES IgG, SERUM
Mounting:
Delivery period:21
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 10 Ratio
Review:
14/12/2014
14403
ASCA (SACCHAROMYCES CEREVISAE ANTIBODIES) IgG, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 20.1 - 24.9 U
Positive:
>= to 25.0 U
Negative:
< 20.0 U
Review:
18/11/2014
14404
ASCA (SACCHAROMYCES CEREVISAE ANTIBODIES) IgA, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 20.1 - 24.9 U
Positive:
>= to 25.0 U
Negative:
< 20.0 U
Review:
19/11/2014
14434
ALDOSTERONA at -30 minuts, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Serum (-8 ºC - Freeze)
Alt. 1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Plasma Heparin lithium (-8 ºC - Freeze)
Reference V.:

Standing position 0.09 - 0.83 nmol/L * 361.011 = ng/L
Supine position 0.02 - 0.42 nmol/L * 361.011 = ng/L
Review:
17/12/2014
14435
ALDOSTERONE a -15 minuts, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Serum (-8 ºC - Freeze)
Alt. 1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Plasma Heparin lithium (-8 ºC - Freeze)
Reference V.:

Standing position 0.09 - 0.83 nmol/L * 361.011 = ng/L
Supine position 0.02 - 0.42 nmol/L * 361.011 = ng/L
Review:
17/12/2014
14550
ACTIN ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:10
Sample:
0.5 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
16/02/2015
14619
ANGIOEDEMA HEREDITARY TYPE 1 (SERPING1 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
09/02/2015
14624
AMYOTROPHIC LATERAL SCLEROSIS (C9ORF72 GENE), BLOOD
Method:
PCR-Fragment length analysis+TP PCR.
Mounting:
Delivery period:35
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
20/02/2015
14778
AMIKACIN PEAK, SERUM
Method:
Polarized Immunofluorescense.
Mounting:
Delivery period:1
Sample:
1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Or 30 miutes after endovenous infusionion or 60 minutes after intramuscular administration (PEAK).
Therapeutic R.:
34.20 - 51.30 umol/L * 0.584795 = ug/mL
Toxic C.:
> 51.30 umol/L * 0.584795 = ug/mL
Review:
10/06/2015
14779
AMIKACIN THROUGH, SERUM
Method:
Polarized Immunofluorescense.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Specimens must be obtained 30 minutes before next administration (TROUGH) .
Toxic C.:

Trough > 17.10 umol/L * 0.584795 = ug/mL
Therapeutic R.:

1.71 - 6.84 umol/L * 0.584795 = ug/mL
Review:
10/06/2015
14789
ANEURYSM AORTIC FAMILIAL (ACTA2 GENE: NGS), BLOOD
Method:
Next Generation Sequencing (NGS)
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14830
ANGIOEDEMA HEREDITARY TYPE 1 (SERPING1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14859
ALPHA-FETOPROTEIN, CSF
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
< 1.50 ug/L * 0.83 = UI/mL
Review:
16/09/2015
14861
ALDOSTERONE Tube 1, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Serum Tube 1 (-8 ºC - Freeze)
Reference V.:
Review:
12/09/2015
14862
ALDOSTERONE Tube 2, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Serum Tube 2 (-8 ºC - Freeze)
Reference V.:
Review:
12/09/2015
14863
ALDOSTERONE Tube 3, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Serum Tube 3 (-8 ºC - Freeze)
Reference V.:
Review:
12/09/2015
14864
ALDOSTERONE Tube 4, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Serum Tube 4 (-8 ºC - Freeze)
Reference V.:
Review:
12/09/2015
14906
AICARDI-GOUTIERES SYNDROME (RNASEH2B GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood EDTA Na (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15011
ARGININOSUCCINIC ACIDURIA (ASL GENE), CHORIONIC VILLI
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
0.01 g Corial villus RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15036
ALBINISME OCULOCUTANEOUS TYPE 1 (TYR GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15037
ACIDE 1, 2 DIHYDROXYBUTYLMERCAPTURIC, URINE
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:20
Sample:
10 mL End-of-day urine (-8 ºC - Freeze)
Reference V.:
< 2.50 mg/L
15071
ARRAY-CGH (MOLECULAR KARYOTYPE) POSTNATAL (180K), BLOOD
Method:
Array - CGH (Array Comparative Genomic Hybridization).
Mounting:
Delivery period:17
Sample:
5 mL Total blood EDTA Na (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15086
ARYLSULFATASE A, LEUCOCYTES
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:35
Sample:
10 All Total blood Heparin lithium (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
It´s necessary to contact previously with the laboratory for study programmation..
Reference V.:
73.00 - 215.00 nmol/17h/mg prot.
15094
ARRAY-CGH IN MENTAL RETARDATION AND AUTISME(180K), BLOOD
Method:
Array - CGH (Array Comparative Genomic Hybridization).
Mounting:
Delivery period:28
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15115
AMPHETAMINES (CONFIRMATORY), SERUM
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:15
Sample:
2 mL Serum (-8 ºC - Freeze)
Discriminant V.:
100.00 ug/L
Reference V.:
Negative
15209
ARGINASE, ERYTHROCYTES
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:32
Sample:
3 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
It´s necessary the birth date.
It´s necessary to contact previously with the laboratory for study programmation..
Reference V.:
3741.00 - 7805.00 umol/h/g Hb
15210
ALPHA 1, 4 GLUCOSIDASE, LYMPHOCYTES
Method:
Fluorimetry
Mounting:
Delivery period:32
Sample:
15 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
It´s necessary the birth date.
It´s necessary to contact previously with the laboratory for study programmation..
Reference V.:
6.00 - 32.00 nmol/h/mg
15241
AMANYTINES, URINE
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:3
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
< 5.00 ng/mL
15266
ALBRIGHT OSTEODYSTROPHIY (GNAS GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15305
ACANTHAMOEBA spp DNA, BIOLOGICAL FLUID
Method:
Polymerase chain reaction.
Mounting:
Delivery period:10
Sample:
1 mL Vitreous humour/aqueous (2-8 ºC - Refrigerate)
Reference V.:
Negative
15309
ACHONDROGENESIS 1B (SLC26A2 GENE), CHORIONIC VILLI
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
0.02 g Corial villus (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15317
ARRAY-CGH POSTNATAL (MOLECULAR KARYOTYPE) (400K), BLOOD
Method:
Array - CGH (Array Comparative Genomic Hybridization).
Mounting:
Delivery period:17
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15395
ANION GAP, SERUM
Method:
Calculation
Mounting:
Delivery period:3
Sample:
1 mL Plasma Heparin lithium (-8 ºC - Freeze)
1 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Cap tube immediately to avoid contact with air.
Reference V.:
8.00 - 16.00 mEq/L
15398
ALDOSTERONE, SERUM after deambulation
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:4
Sample:
1 mL Serum (-8 ºC - Freeze)
Alt. 1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Plasma Heparin lithium (-8 ºC - Freeze)
15399
ALDOSTERONE, Post Saline SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:4
Sample:
1 mL Serum (-8 ºC - Freeze)
Alt. 1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Plasma Heparin lithium (-8 ºC - Freeze)
15406
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA(JUP GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15424
AUTOIMMUNE POLYENOCRINE SYNDROME (AIRE GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15566
ACYL-COA DEHYDROGENASE SHORT CHAIN DEFICIENCY (ACADS GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15567
ACIL-COA DH SHORT CHAIN DEFICIENCIY (ACADS GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15568
ACYL-COA DH SHORT CHAINDEFICIENCY (ACADS GENE), AMNIOTIC FLUID
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15583
ALEXANDER DISEASE (GFAP GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15594
ANNEXIN A5 GENE M2 HAPLOTYPE, BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:15
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
R.Values:
NOTE: The Annexin A5 gene M2 haplotype presence (rs112782763G>A, rs28717001A>C, rs28651243T>C y rs113588187G>A) on the matern and/or patern blood sample, seems to be associated with a higher recurrent pregnancy loss.

Multicentre study of the clinical relevance of screening IVF patients for carrier status of the annexin A5M2 haplotype.Simon Fishel et al. Reproductive Biomedicine Online(2014) 29, 80-87.
15618
ANDROGEN INSENSITIVITY (AR GENE;: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15629
ATRIAL SEPTAL DEFECT 7 (NKX2-5 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15630
ATRIAL SEPTAL DEFECT 7 (NKX2-5 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15633
ALDOSTERONE, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Serum (-8 ºC - Freeze)
Alt. 1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:

Standing position 0.08 - 0.75 nmol/L * 361.011 = ng/L
Supine position 0.04 - 0.40 nmol/L * 361.011 = ng/L
R.Values:
Values for adults with a daily sodium intake of 100 - 150 mmol/day.
15634
ALDOSTERONE, SERUM BASELINE
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Baseline serum (-8 ºC - Freeze)
Alt. 1 mL Baseline plasma Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Baseline plasma Heparin lithium (-8 ºC - Freeze)
Reference V.:

Standing position 0.08 - 0.75 nmol/L * 361.011 = ng/L
Supine position 0.04 - 0.40 nmol/L * 361.011 = ng/L
R.Values:
Values for adults with a daily sodium intake of 100 - 150 mmol/day.
15635
ALDOSTERONE, SERUM Standing position
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Standing position serum (-8 ºC - Freeze)
Alt. 1 mL Standing position plasma Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Standing position plasma Heparin lithium (-8 ºC - Freeze)
Reference V.:
0.08 - 0.75 nmol/L * 361.011 = ng/L
R.Values:
Values for adults with a daily sodium intake of 100 - 150 mmol/day.
15636
ALDOSTERONE, SERUM Supine position
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:3
Sample:
1 mL Supine position serum (-8 ºC - Freeze)
Alt. 1 mL Supine position plasma Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Supine position plasma Heparin lithium (-8 ºC - Freeze)
Reference V.:
0.04 - 0.40 nmol/L * 361.011 = ng/L
R.Values:
Values for adults with a daily sodium intake of 100 - 150 mmol/day.
15696
ALDOSTERONE, SERUM 180 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:2
Sample:
1 mL Serum 180m (-8 ºC - Freeze)
Alt. 1 mL Plasma 180m Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Plasma 180m Heparin lithium (-8 ºC - Freeze)
Reference V.:
Not available
15716
ARRYTHMOGENIC RIGHT VENT. DYSPLASIA (PKP2 GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15739
ALPRAZOLAM, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:8
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
5.00 - 20.00 µg/L * 0.003239 = µmol/L
15762
ALPHA1-ANTITRYPSIN DEFICIENCY (SERPINA1 GENE), CHORYONIC VILLI
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
0.01 g Corial villus (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15775
AUTOINFLAMATORIY DISEASES (3 GENES PANEL: NGS), BLOOD
Method:
Next Generation Sequencing (NGS).
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15776
AUTOINFLAMATORIY DISEASES (18 GENES PANEL: NGS), BLOOD
Method:
Next Generation Sequencing (NGS).
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15906
ADMA (ASIMMETRIC DIMETHYLARGININE), SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:7
Sample:
0.6 mL Serum (-8 ºC - Freeze)
Alt. 0.6 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Reference V.:
0.30 - 0.80 umol/L
15917
ALDOSTERONE, SERUM 300 m
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:2
Sample:
1 mL Serum 300 m. (-8 ºC - Freeze)
Alt. 1 mL Plasma 300 min. Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Plasma 300 min. Heparin lithium (-8 ºC - Freeze)
Reference V.:
Not available
15927
ANGELMAN SYNDROME (REGION 15q11: MS-MLPA), VELLOSIDAD CORIAL
Method:
Metilation specífic MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:20
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
16005
ALPORT SYNDROME (3 GENES COL4A3, COL4A4 and COL4A5 PANEL: NGS), BLOOD
Method:
Next Generation Sequencing (NGS).
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
16006
AUTOIMMUNE POLYENDOCRINE SYNDROME (AIRE GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
16099
ADIPONECTIN, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
1 mL Serum (-8 ºC - Freeze)
Reference V.:
High relative risk: 4.00 - 7.00 ug/mL
Intermediate relative risk7.00 - 10.00 ug/mL
Low relative risk:
> 10.00 ug/mL
Risc Relative Very High:
< 4.00 ug/mL
16106
AMIKACIN, SERUM
Method:
Homogeneous enzyme immunoassay (EMIT).
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Specimens must be obtained 30 minutes before next administration (TROUGH) .
Or 30 miutes after endovenous infusionion or 60 minutes after intramuscular administration (PEAK).
Therapeutic R.:

Peak 43.00 - 60.00 umol/L * 0.584795 = ug/mL
Trough 2.00 - 14.00 umol/L * 0.584795 = ug/mL
Toxic C.:

Peak > 60.00 umol/L * 0.584795 = ug/mL
Trough > 17.00 umol/L * 0.584795 = ug/mL
16107
AMIKACIN PEAK, SERUM
Method:
Enzyme multiplied immunoassay technique.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Or 30 miutes after endovenous infusionion or 60 minutes after intramuscular administration (PEAK).
Therapeutic R.:
43.00 - 60.00 umol/L * 0.584795 = ug/mL
Toxic C.:
> 60.00 umol/L * 0.584795 = ug/mL
16108
AMIKACIN THROUGH, SERUM
Method:
Enzyme multiplied immunoassay technique.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Specimens must be obtained 30 minutes before next administration (TROUGH) .
Therapeutic R.:

Trough 2.00 - 14.00 umol/L * 0.584795 = ug/mL
Toxic C.:

> 17.00 umol/L * 0.584795 = ug/mL